ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,525.21
      0.74%
      US Tech 100
      18,919.76
      1.21%
      Dow Jones
      40,113.50
      0.05%
      Brent Oil
      66.025
      0.00%
      Bitcoin
      94,326.11
      -0.42%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. CureVac NV (CVAC) Quote

      CureVac NV

      CureVac NV (CVAC)

      NASDAQ
      3.23
      -0.03
      (-0.92%)
      Closed April 26 4:00PM
      Delayed by 15 minutes
      3.21
      -0.02
      (-0.62%)
      After Hours: 5:59PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      3.21
      Bid
      3.13
      Ask
      3.43
      Volume
      350,704
      3.20 Day's Range 3.3803
      2.215 52 Week Range 5.28
      Market Cap
      722.75M
      Previous Close
      3.26
      Open
      3.37
      Last Trade
      6
      @
      3.26
      Last Trade Time
      Financial Volume
      $ 1,151,773
      VWAP
      3.2842
      Average Volume (3m)
      628,236
      Shares Outstanding
      225,155,874
      Dividend Yield
      -
      PE Ratio
      -2.80
      Earnings Per Share (EPS)
      -1.16
      Revenue
      61.71M
      Net Profit
      -260.17M

      About CureVac NV

      CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GlaxoSmithKline to develop a second-gen... CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GlaxoSmithKline to develop a second-generation COVID-19 vaccine. CureVac's first attempt to develop a COVID-19 vaccine did not have sufficient efficacy data, and its trials were discontinued in October 2021. The company's other pipeline candidates include mRNA vaccines for influenza, rabies, and malaria. Additionally, CureVac is in the early stages of development for oncology and molecular therapies spanning tumors, liver, ocular, and lung diseases. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.curevac.com
      Headquarters
      Tubingen, Deu
      Founded
      -
      CureVac NV is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CVAC. The last closing price for CureVac NV was $3.26. Over the last year, CureVac NV shares have traded in a share price range of $ 2.215 to $ 5.28.

      CureVac NV currently has 225,155,874 shares outstanding. The market capitalization of CureVac NV is $734.01 million. CureVac NV has a price to earnings ratio (PE ratio) of -2.80.

      Ask ADVFN Intelligence (AI)

      CVAC Latest News

      More News

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
      Edgar (US Regulatory)
      April 10 2025
      CVAC (-0.92%)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
      Edgar (US Regulatory)
      April 07 2025
      CVAC (-0.92%)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
      Edgar (US Regulatory)
      March 27 2025
      CVAC (-0.92%)

      Form 144 - Report of proposed sale of securities
      Edgar (US Regulatory)
      January 07 2025
      CVAC (-0.92%)

      Form 144 - Report of proposed sale of securities
      Edgar (US Regulatory)
      January 07 2025
      CVAC (-0.92%)

      Form 144 - Report of proposed sale of securities
      Edgar (US Regulatory)
      January 07 2025
      CVAC (-0.92%)

      Form 144 - Report of proposed sale of securities
      Edgar (US Regulatory)
      January 07 2025
      CVAC (-0.92%)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
      Edgar (US Regulatory)
      November 12 2024
      CVAC (-0.92%)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
      Edgar (US Regulatory)
      November 12 2024
      CVAC (-0.92%)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
      Edgar (US Regulatory)
      November 04 2024
      CVAC (-0.92%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.092.884615384623.123.323.063846393.2024306CS
      4-0.08-2.431610942253.293.332.4756998962.94778113CS
      12-0.655-16.94695989653.8653.952.4756282363.15348789CS
      260.4918.01470588242.7252.376950983.34484967CS
      520.7329.4354838712.485.282.2158027833.44003813CS
      156-12.98-80.172946263116.1920.062.2157390836.49652313CS
      260-81.78-96.223085068884.991332.21579037431.12757458CS

      CVAC - Frequently Asked Questions (FAQ)

      What is the current CureVac NV share price?
      The current share price of CureVac NV is $ 3.21
      How many CureVac NV shares are in issue?
      CureVac NV has 225,155,874 shares in issue
      What is the market cap of CureVac NV?
      The market capitalisation of CureVac NV is USD 734.01M
      What is the 1 year trading range for CureVac NV share price?
      CureVac NV has traded in the range of $ 2.215 to $ 5.28 during the past year
      What is the PE ratio of CureVac NV?
      The price to earnings ratio of CureVac NV is -2.8
      What is the cash to sales ratio of CureVac NV?
      The cash to sales ratio of CureVac NV is 11.78
      What is the reporting currency for CureVac NV?
      CureVac NV reports financial results in EUR
      What is the latest annual turnover for CureVac NV?
      The latest annual turnover of CureVac NV is EUR 61.71M
      What is the latest annual profit for CureVac NV?
      The latest annual profit of CureVac NV is EUR -260.17M
      What is the registered address of CureVac NV?
      The registered address for CureVac NV is FRIEDRICH-MIESCHER-STRASSE 15, TUBINGEN, 72076
      What is the CureVac NV website address?
      The website address for CureVac NV is www.curevac.com
      Which industry sector does CureVac NV operate in?
      CureVac NV operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      WWWW International Inc
      $ 0.395
      (167.62%)
      		223.58M
      OMEXOdyssey Marine Exploration Inc
      $ 1.4979
      (75.79%)
      		285.65M
      RTCBaijiayun Group Ltd
      $ 0.3244
      (74.88%)
      		263.23M
      GREEGreenidge Generation Holdings Inc
      $ 1.3197
      (53.92%)
      		5.84M
      SXTCChina SXT Pharmaceuticals Inc
      $ 2.28
      (44.30%)
      		38.04M
      CGTLCreative Global Technology Holdings Ltd
      $ 1.5197
      (-75.09%)
      		3.88M
      TOIIWOncology Institute Inc
      $ 0.1015
      (-40.22%)
      		156.14k
      COEPCoeptis Therapeutics Holdings Inc
      $ 7.70
      (-38.25%)
      		716.99k
      INTSIntesity Therapeutics Inc
      $ 0.56
      (-37.78%)
      		3.21M
      SMMTSummit Therapeutics Inc
      $ 23.47
      (-36.05%)
      		24.67M
      GNLNGreenlane Holdings Inc
      $ 0.012699
      (-15.34%)
      		355.22M
      AGMHAGM Group Holdings Inc
      $ 0.0477
      (22.31%)
      		340.91M
      OMEXOdyssey Marine Exploration Inc
      $ 1.4979
      (75.79%)
      		285.65M
      TSLLDirexion Daily TSLA Bull 2X Trust ETF
      $ 10.455
      (19.62%)
      		266.95M
      RTCBaijiayun Group Ltd
      $ 0.3244
      (74.88%)
      		263.23M

      CVAC Discussion

      View Posts
      tw0122 tw0122 4 weeks ago
      $3.15 + 12% MRNA lawsuit could make them some cash. Patent valid 
      👍️0
      TrendTrade2016 TrendTrade2016 5 months ago
      CVAC IN HERE...WHAT A BALANCE SHEET
      👍️0
      Monksdream Monksdream 8 months ago
      CVAC under $4
      👍️0
      tw0122 tw0122 11 months ago
      There is a cure again
      👍️0
      Monksdream Monksdream 1 year ago
      CVAC new 52 week low
      👍️0
      Monksdream Monksdream 1 year ago
      CVAC new 52 week low
      👍️0
      Monksdream Monksdream 1 year ago
      CVAC new 52 week low
      👍️0
      Monksdream Monksdream 1 year ago
      CVAC new 52 week low
      👍️0
      mick mick 1 year ago
      https://www.otcmarkets.com/stock/CVAC
      👍️0
      mick mick 1 year ago
      https://www.otcmarkets.com/stock/CVAC
      👍️0
      mick mick 1 year ago
      https://www.otcmarkets.com/stock/CVAC
      👍️0
      mick mick 2 years ago
      https://www.otcmarkets.com/stock/CVAC
      👍️0
      mick mick 2 years ago
      https://www.otcmarkets.com/stock/CVAC
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      8.99
      0.09 (1.01%)
      Volume: 232,857
      Day Range: 8.73 - 9.15
      Last Trade Time: 6:30:54 PM EDT
      👍️0
      Mr. Pearson Mr. Pearson 2 years ago
      Big News coming soon... just be patient....
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      10.98
      1.30 (13.43%)
      Volume: 464,848
      Day Range: 9.72 - 10.47
      Last Trade Time: 7:53:28 PM EDT
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      10.98
      1.30 (13.43%)
      Volume: 464,848
      Day Range: 9.72 - 10.47
      Last Trade Time: 7:53:28 PM EDT
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      10.98
      1.30 (13.43%)
      Volume: 464,848
      Day Range: 9.72 - 10.47
      Last Trade Time: 7:53:28 PM EDT
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      12.23
      0.80 (7.00%)
      Volume: 2,433,695
      Day Range: 11.02 - 12.36
      Last Trade Time: 7:59:28 PM EDT
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      12.23
      0.80 (7.00%)
      Volume: 2,433,695
      Day Range: 11.02 - 12.36
      Last Trade Time: 7:59:28 PM EDT
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      9.15
      -0.28 (-2.97%)
      Volume: 373,244
      Day Range: 9.06 - 9.49
      Last Trade Time: 6:38:15 PM EDT
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      7.37
      0.05 (0.68%)
      Volume: 613,302
      Day Range: 7.28 - 7.40
      Last Trade Time: 7:50:44 PM EDT
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      7.79
      -0.11 (-1.39%)
      Volume: 227,150
      Day Range: 7.66 - 8.13
      Last Trade Time: 5:09:42 PM EDT
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      7.79
      -0.11 (-1.39%)
      Volume: 227,150
      Day Range: 7.66 - 8.13
      Last Trade Time: 5:09:42 PM EDT
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      7.79
      -0.11 (-1.39%)
      Volume: 227,150
      Day Range: 7.66 - 8.13
      Last Trade Time: 5:09:42 PM EDT
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      7.79
      -0.11 (-1.39%)
      Volume: 227,150
      Day Range: 7.66 - 8.13
      Last Trade Time: 5:09:42 PM EDT
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      8.50
      -0.16 (-1.85%)
      Volume: 641,450
      Day Range: 8.52 - 8.68
      Last Trade Time: 7:00:46 PM EST
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      11.06
      -0.62 (-5.31%)
      Volume: 537,147
      Day Range: 11.01 - 11.83
      Last Trade Time: 7:55:22 PM EST
      👍️0
      mick mick 2 years ago
      it is relative CureVac (CVAC) Receives a Buy from Berenberg Bank
      August 23 2022 - 09:55PM
      TipRanks
      Alert
      Print
      Share On Facebook
      In a report released yesterday, Zhiqiang Shu from Berenberg Bank maintained a Buy rating on CureVac (CVAC - Research Report), with a price target of $45.00. The company's shares closed yesterday at $11.32.Shu covers the Healthcare sector, focusing on stocks such as Alnylam Pharma, Arcus Biosciences, and Sutro Biopharma. According to TipRanks, Shu has an average return of -21.0% and a 23.78% success rate on recommended stocks. Currently, the analyst consensus on CureVac is a Moderate Buy with an average price target of $28.50, implying a 151.77% upside from current levels.
      https://www.tipranks.com/news/blurbs/curevac-cvac-receives-a-buy-from-berenberg-bank?utm_source=advfn.com&utm_medium=referral
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      6.60
      -0.21 (-3.08%)
      Volume: 387,429
      Day Range: 6.58 - 6.99
      Last Trade Time: 4:09:13 PM EST
      👍️0
      mick mick 2 years ago
      i think $CVAC is ah buyout candidate /\

      let's say $40
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      6.81
      0.04 (0.59%)
      Volume: 1,065,479
      Day Range: 6.52 - 6.93
      Last Trade Time: 4:46:47 PM EST
      👍️0
      mick mick 3 years ago
      CVAC
      CureVac NV
      7.49
      0.28 (3.88%)
      Volume: 181,787
      Day Range: 7.155 - 7.49
      Bid: 6.13
      Ask: 9.18
      Last Trade Time: 4:13:18 PM EDT
      Total Trades: 1,819
      CVAC Detailed Quote
      👍️0
      mick mick 3 years ago
      CVAC
      CureVac NV
      7.49
      0.28 (3.88%)
      Volume: 181,787
      Day Range: 7.155 - 7.49
      Bid: 6.13
      Ask: 9.18
      Last Trade Time: 4:13:18 PM EDT
      Total Trades: 1,819
      CVAC Detailed Quote
      👍️0
      mick mick 3 years ago
      CVAC
      CureVac N.V.
      Ordinary Shares
      9.84
      -0.40

      -3.90%

      Delayed (15 Min) Trade Data: 04:00pm 08/31/2022
      Overview
      Quote
      Company Profile
      Security Details
      News
      Financials
      Disclosure
      Research
      👍️0
      mick mick 3 years ago
      we don't show quote ?????
      👍️0
      mick mick 3 years ago
      we don't show quote ?????
      👍️0
      mick mick 3 years ago
      CureVac (CVAC) Receives a Buy from Berenberg Bank
      August 23 2022 - 09:55PM
      TipRanks
      Alert
      Print
      Share On Facebook
      In a report released yesterday, Zhiqiang Shu from Berenberg Bank maintained a Buy rating on CureVac (CVAC - Research Report), with a price target of $45.00. The company's shares closed yesterday at $11.32.Shu covers the Healthcare sector, focusing on stocks such as Alnylam Pharma, Arcus Biosciences, and Sutro Biopharma. According to TipRanks, Shu has an average return of -21.0% and a 23.78% success rate on recommended stocks. Currently, the analyst consensus on CureVac is a Moderate Buy with an average price target of $28.50, implying a 151.77% upside from current levels.
      https://www.tipranks.com/news/blurbs/curevac-cvac-receives-a-buy-from-berenberg-bank?utm_source=advfn.com&utm_medium=referral
      👍️0
      mick mick 3 years ago
      CVAC
      CureVac NV
      12.62
      -0.03 (-0.24%)
      Volume: 276,718
      Day Range: 12.39 - 12.79
      Bid: 12.60
      Ask: 13.18
      Last Trade Time: 4:57:18 PM EDT
      Total Trades: 3,775
      CVAC Detailed Quote
      👍️0
      sdy sdy 3 years ago
      Interesting new Beneficial Owners recently. Taken an entry position today.
      Looks like Covid-19 vaccines still hold prominent place in biotech research: "CureVac and GSK's second-generation vaccine candidate targeting two recent COVID-19 variants has been shown to be highly effective in preclinical studies on mice, CureVac said, as it seeks to catch up with rivals' development work." https://finance.yahoo.com/news/1-curevac-gsks-experimental-covid-124419805.html
      👍️0
      mick mick 3 years ago
      CureVac NV (CVAC)
      18.18 ? -0.65 (-3.45%)
      Volume: 402,327 @06/03/22 6:58:05 PM EDT
      Bid Ask Day's Range
      17.61 20.1 17.56 - 18.58
      CVAC Detailed Quote
      👍️0
      mick mick 3 years ago
      CureVac NV (CVAC)
      18.18 ? -0.65 (-3.45%)
      Volume: 402,327 @06/03/22 6:58:05 PM EDT
      Bid Ask Day's Range
      17.61 20.1 17.56 - 18.58
      CVAC Detailed Quote
      👍️0
      mick mick 3 years ago
      https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-contrafect-cfrx-curevac-cvac?utm_source=advfn.com&utm_medium=referral
      👍️0
      mick mick 3 years ago
      https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-contrafect-cfrx-curevac-cvac?utm_source=advfn.com&utm_medium=referral
      👍️0
      mick mick 3 years ago
      CureVac NV (CVAC)
      17.205 ? 0.625 (3.77%)
      Volume: 164,845 @04/29/22 1:27:43 PM EDT
      Bid Ask Day's Range
      17.2 17.25 16.47 - 17.44
      CVAC Detailed Quote
      👍️0
      mick mick 3 years ago
      CureVac NV (CVAC)
      15.69 ? -1.08 (-6.44%)
      Volume: 305,719 @03/11/22 5:11:50 PM EST
      Bid Ask Day's Range
      15.7 16.66 15.68 - 17.225
      CVAC Detailed Quote
      👍️0
      mick mick 3 years ago
      CureVac NV (CVAC)
      18.19 ? 0.05 (0.28%)
      Volume: 587,579 @02/04/22 5:09:58 PM EST
      Bid Ask Day's Range
      17.05 19.74 17.7685 - 18.61
      CVAC Detailed Quote
      👍️0
      mick mick 3 years ago
      https://www.otcmarkets.com/stock/CVAC
      👍️0
      mick mick 3 years ago
      https://www.otcmarkets.com/stock/CVAC
      👍️0
      2times2 2times2 3 years ago
      CureVac Says Preclinical Trial Shows Antibody Levels of COVID-19 Vaccine Candidate CV2CoV 'Highly Comparable' With Pfizer's mRNA Vaccine
      MT NEWSWIRES 3:11 PM ET 11/18/2021

      03:11 PM EST, 11/18/2021 (MT Newswires) -- CureVac(CVAC) said Thursday the extended preclinical study of the second-generation vaccine candidate, CV2CoV, showed that neutralizing antibody levels after full vaccination of animals were "highly comparable" with Pfizer (PFE) and BioNTech's (BNTX) licensed mRNA vaccine, Comirnaty.

      CureVac (CVAC) is developing CV2CoV in partnership with GlaxoSmithKline (GSK). Animals were vaccinated with either 12 micrograms of CV2CoV or a 30 microgram standard dose of Comirnaty.

      Data showed that targeted optimizations of a non-chemically modified mRNA can significantly improve immune responses in a preclinical model.

      👍️0

      Your Recent History

      NASDAQ
      CVAC
      CureVac NV
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads